4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-22-018829
CBO & EVP sold 10,281 shares at $67.01 ($688,930)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kassberg Thomas Richard CBO & EVP | 2022-03-11 | Sale | −10,281 | $67.01 | $688,930 | 227,559 | D: show line 1 in the form |
| Open-market sales · 10,281 sh · avg $67.01 · $688,930 | |||||||
Loading xslF345X03/doc4.xml…